Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-ablative Cryosurgical Freezing and Multiplex Immunotherapy in Metastatic Solid Cancer
NCT04739618Phase 2Active, not recruiting
- Sponsor
- ImmunSYS, Inc.
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, ipilimumab, sargramostim in metastatic cancer, sponsored by ImmunSYS, Inc.. Started Mar 2021; status: active, not recruiting.
02
Drugs
03
Conditions
metastatic cancer
Beyond the preview
Go deeper on NCT04739618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739618.